ADMA BIOLOGICS INC's ticker is ADMA and the CUSIP is 000899104. A total of 19 filers reported holding ADMA BIOLOGICS INC in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $90,000 | -10.0% | 22,500 | 0.0% | 0.01% | -15.4% |
| Q3 2019 | $100,000 | -40.5% | 22,500 | -39.9% | 0.01% | +30.0% |
| Q2 2018 | $168,000 | +64.7% | 37,460 | +68.7% | 0.01% | +42.9% |
| Q1 2018 | $102,000 | +161.5% | 22,200 | +107.5% | 0.01% | +250.0% |
| Q2 2017 | $39,000 | -57.1% | 10,700 | -43.0% | 0.00% | -66.7% |
| Q1 2017 | $91,000 | +33.8% | 18,787 | +40.4% | 0.01% | 0.0% |
| Q4 2016 | $68,000 | -75.9% | 13,380 | -65.7% | 0.01% | -73.9% |
| Q3 2016 | $282,000 | +51.6% | 39,000 | +24.6% | 0.02% | +35.3% |
| Q2 2016 | $186,000 | +67.6% | 31,300 | +126.8% | 0.02% | +54.5% |
| Q1 2016 | $111,000 | +26.1% | 13,800 | +25.5% | 0.01% | 0.0% |
| Q4 2015 | $88,000 | -14.6% | 11,000 | -1.8% | 0.01% | -21.4% |
| Q2 2015 | $103,000 | -21.4% | 11,200 | -18.8% | 0.01% | -22.2% |
| Q1 2015 | $131,000 | – | 13,800 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Velan Capital Investment Management LP | 4,000,000 | $15,520,000 | 13.71% |
| Stonepine Capital Management, LLC | 6,940,000 | $26,927,200 | 11.33% |
| Caligan Partners LP | 2,676,093 | $10,383,241 | 8.64% |
| Altium Capital Management LP | 2,870,000 | $11,135,600 | 5.66% |
| AWM Investment Company, Inc. | 6,015,000 | $23,338,200 | 3.36% |
| EAM Investors, LLC | 1,749,598 | $6,788,440 | 1.40% |
| Perceptive Advisors | 11,900,255 | $46,172,989 | 1.30% |
| EAM Global Investors LLC | 836,323 | $3,244,933 | 0.84% |
| Potomac Capital Management, Inc. | 120,000 | $466 | 0.54% |
| OBERWEIS ASSET MANAGEMENT INC/ | 536,900 | $2,083,172 | 0.44% |